ADIM
RH icon

Alpha DNA Investment Management’s RH RH Stock Holding History

Alpha DNA Investment Management’s Portfolio RH Stock Details RH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,956
Closed -$1.3M – 142
2021
Q3 		$1.3M Buy
1,956
+474
+32% +$326K 0.89% 89
2021
Q2 		$1.01M Buy
1,482
+1,473
+16,367% +$957K 0.69% 96
2021
Q1 		$5K Sell
9
-260
-97% -$128K 0.01% 377
2020
Q4 		$120K Buy
+269
New +$111K 0.13% 128

Other funds holding RH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCP
D1 Capital Partners New York $34.8B AUM 11.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DCP
Darsana Capital Partners New York $22.3B AUM 42.01% 1-Year Est. Return

Alpha DNA Investment Management's RH Position: Q4 2021 in Review

Alpha DNA Investment Management sold out of RH (RH) in Q4 2021, closing a stake of 1,956 shares — an estimated $1.3M sold.

Alpha DNA Investment Management first reported a position in RH in Q4 2020 and held it in 4 quarters. The position peaked at $1.3M in Q3 2021. 481 funds tracked by Wall St. Rank hold RH as of Q4 2021.

  • Alpha DNA Investment Management reported no remaining RH position as of Q4 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 1,956 RH shares in Q4 2021, an estimated $1.3M.
  • Alpha DNA Investment Management first reported a position in RH in Q4 2020 and held it in 4 quarters.
  • Alpha DNA Investment Management's RH position peaked at $1.3M in Q3 2021.
  • 481 funds tracked by Wall St. Rank held RH as of Q4 2021.

Based on Alpha DNA Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.